Pramila Jayapal calls for release of files allegedly linking Trump to Epstein

U.S. Rep. Pramila Jayapal representing Washington%27s 7th Congressional District - Official U.S. House headshot
U.S. Rep. Pramila Jayapal representing Washington's 7th Congressional District - Official U.S. House headshot
0Comments

U.S. Representative Pramila Jayapal, who serves Washington’s 7th district in Congress, made a series of posts on July 23, 2025, criticizing former President Donald Trump’s appointees and calling for the release of files allegedly linking Trump to Jeffrey Epstein.

In her first post at 19:20 UTC, Jayapal wrote: “Trump’s appointees have ZERO IDEA what they are doing or what their jobs are. Breathtaking and staggering incompetence. I truly could not believe what I was hearing.”

Five minutes later, she added: “And now we know exactly what Trump has been so afraid of. Release the files.”

Later that evening at 21:06 UTC, Jayapal posted: “BREAKING: The Justice Department told Trump that his name is in the Epstein Files. The public deserves answers. Release all of the files NOW.”

Pramila Jayapal has represented Washington’s 7th District in Congress since 2017 after previously serving in the Washington State Senate from 2014 to 2016. She succeeded Jim McDermott as U.S. Representative and currently resides in Seattle. Born in Chennai in 1965, Jayapal holds degrees from Georgetown University and Northwestern University.



Related

Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA

FDA inspects InnerSea Discoveries – Wilderness Discoverer, LLC in Seattle on July 21, 2024

On July 21, 2024, InnerSea Discoveries – Wilderness Discoverer, LLC in Seattle underwent an FDA inspection focused on food and cosmetics technical assistance, according to information available on the FDA’s website.

Mark Raza Principal Deputy Chief Counsel - FDA

Mark N. Fluchel, M.D. in Seattle scheduled for FDA inspection on Nov. 21, 2024

Mark N. Fluchel, M.D., based in Seattle, underwent an FDA bioresearch monitoring inspection on November 21, 2024, according to information available on the FDA’s website.

James “Jim” Sigg FDA's Deputy Commissioner for Operations and Chief Operating Officer

Kalsada Coffee Company in Seattle inspected by FDA on July 1, 2024

The Food and Drug Administration conducted an inspection of Kalsada Coffee Company in Seattle on July 1, 2024, focusing on foodborne biological hazards, according to FDA website data.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Seattle City Wire.